首页> 外文期刊>BMC Infectious Diseases >Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis
【24h】

Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis

机译:非HIV隐球菌性脑膜炎患者脑脊液中补体系统的活性增加

获取原文
           

摘要

Backgrounds Cryptococcal meningitis (CM) has been known to lead to significant morbidity and mortality. The relative contribution of the complement system in protection and pathogenesis during CM remains largely unknown. The purpose of this study was to evaluate the baseline complement component profiles in human cerebrospinal fluid (CSF) and plasma from non-HIV patients with CM, and therefore to provide insights of possible roles of the complement system in CM. Methods CSF and blood samples from forty two CM patients not infected with HIV and thirteen non-CM control patients (Ctrl) were retrospectively selected and evaluated from the patients admitted to the hospital with a suspected diagnosis of CM. CSF and blood samples were collected at the admission. Enzyme-linked immunosorbent assay (ELISA) for complement components, cytokine IL-12 and western blot for C3 activation were performed on CSF and plasma samples. The levels of complement C1q, factor B (FB), mannose binding lectin (MBL), C2, C3, C4, C5, C4 binding protein (C4BP), Factor I (FI), Factor H (FH), sC5b-9 in CSF and plasma samples were compared. Pearson’s correlation coefficients were calculated on variables between complement components and the levels of total protein in the CSF samples. Results Our data demonstrated that the CSF levels of complement components of C1q, FB, MBL as well as complement pathway factors sC5b-9 and complement regulator FH were all elevated in patients with CM as compared to the controls, CSF C3 breakdown products iC3b were found in both CSF and plasma samples of the CM patients. A positive correlation was found between the levels of CSF protein and MBL, C1q or FB. Conclusions The activity of the complement system in CSF was increased in non-HIV patients with CM. C1q, MBL and FB are the important participants in the complement activation in CM. The relative contribution of each of the specific complement pathways and complement cascades in protection and inflammation resolution against CM warrant further investigation.
机译:背景技术隐球菌性脑膜炎(CM)会导致明显的发病率和死亡率。补体系统在CM期间的保护和发病机制中的相对贡献仍然未知。这项研究的目的是评估非HIV CM患者的人脑脊液(CSF)和血浆中的基线补体成分概况,从而提供有关补体系统在CM中可能作用的见解。方法回顾性分析42例未感染HIV的CM患者和13例非CM对照患者(Ctrl)的脑脊液和血样,并从怀疑患有CM的住院患者中进行评估。入院时收集脑脊液和血液样本。在脑脊液和血浆样品上进行了补体成分的酶联免疫吸附测定(ELISA),细胞因子IL-12和C3活化的蛋白质印迹。补体C1q,B因子(FB),甘露糖结合凝集素(MBL),C2,C3,C4,C5,C4结合蛋白(C4BP),I因子(FI),H因子(FH),sC5b-9的水平比较了脑脊液和血浆样品。皮尔逊相关系数是根据补体成分与脑脊液样品中总蛋白质水平之间的变量计算得出的。结果我们的数据表明,与对照组相比,CM患者的C1q,FB,MBL补体成分,补体途径因子sC5b-9和补体调节因子FH的脑脊液水平均升高,发现脑脊液C3分解产物iC3b在CM患者的CSF和血浆样本中均是如此。发现脑脊液蛋白水平与MBL,C1q或FB之间呈正相关。结论非HIV合并CM患者CSF补体系统活性增加。 C1q,MBL和FB是CM中补体激活的重要参与者。每个特定的补体途径和补体级联在针对CM的保护和消炎中的相对贡献值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号